Real-time enrollment status for this lymphoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 1:04 AM UTC
| NCT Number | NCT05170399 |
| Recruiting Status | Recruiting |
| Condition | Lymphoma |
| Phase | PHASE4 |
| Target Enrollment | 350 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Heart, Lung, and Blood Institute (NHLBI) |
| Last Updated on CT.gov | July 7, 2026 (1 week ago) |
As of July 17, 2026: Clinical trial NCT05170399 is currently recruiting participants. This phase4 study for lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by National Heart, Lung, and Blood Institute (NHLBI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05170399 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05170399 was last updated 1 week ago (July 7, 2026). HelloStudys verifies this status automatically.